Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus

Liver Transplantation

Volumn 13, Issue 12, 2007, Pages 1710-1713

  Kwo, Paul Y ^a   Saxena, Romil ^a   Cummings, Oscar W ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; BILIRUBIN; CORTICOSTEROID; CYCLOSPORIN; ERYTHROPOIETIN; HEMOGLOBIN; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2B; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEASIBILITY STUDY; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; HEPATITIS C; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; RETRANSPLANTATION; VIREMIA; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CHOLESTASIS, INTRAHEPATIC; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; INFUSIONS, INTRAVENOUS; INTERFERON ALFA-2B; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; REOPERATION; RIBAVIRIN; RNA, VIRAL; TIME FACTORS;

EID: 34247246907     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21295     Document Type: Article

References (11)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
2. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002;8(suppl 1):S14-S18.
3. Burton JR Jr, Androsen HR. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States. Clin Gastroenterol Hepatol 2005;3:700-704.
4. Berenguer M, Prieto M, Palau A, Rayon JM, Carrasco D, Juan FS, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003;9:228-235.
5. Gopal DV, Rosen HR. Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite. Liver TranspI 2003;9:348-353.
6. Everson G. Treatment of patients with hepatitis C virus on the waiting list. Liver Transpl 2003;9:S90-S94.
7. Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft. failure: prognostic modeling and ethical considerations. Liver Transpl. 2002;8:313-322.
8. Biggins SW, Terrault NA. Should HCV-related cirrhosis be a contraindication for retransplantation? Liver Transpl 2003;9:236-238.
9. Ghobrial RM. Retransplantation for recurrent hepatitis C. Liver Transpl 2002;8(suppl 1):S38-S43.
10. Garcia-Retortillo M, Forns X, Feliu A, Moitinho, E, Costa J, Navasa M, et al. Hepatitis C virus Idnetics during and immediately after liver transplantation. Hepatology 2002;35:680-687.
11. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005;42:255-262.